We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
NBT Bancorp
NBTB
$2.77B
| $1.05M | ﹤0.01% |
+25,181
| New | +$1.05M |
|
1877
Neumora Therapeutics
NMRA
$313M
| $1.04M | ﹤0.01% |
+583,758
| New | +$1.28M |
|
1878
Sibanye-Stillwater
SBSW
$7.57B
| $1.04M | ﹤0.01% |
73,170
-94,143
| -56% | -$1.14M |
|
1879
Vinci Compass Investments Ltd
VINP
$622M
| $1.04M | ﹤0.01% |
79,760
+26,013
| +48% | +$311K |
|
1880
Sun Communities
SUI
$14.5B
| $1.04M | ﹤0.01% |
+8,384
| New | +$1.05M |
|
1881
Warby Parker
WRBY
$3.12B
| $1.04M | ﹤0.01% |
47,544
-2,012,559
| -98% | -$43.8M |
|
1882
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.33B
| $1.03M | ﹤0.01% |
+21,550
| New | +$1.03M |
|
|
AIV
1883
Aimco
AIV
$378M
| $1.03M | ﹤0.01% |
+173,953
| New | +$1.04M |
|
1884
CALL
Pinduoduo
PDD
$126B
| $1.03M | ﹤0.01% |
9,100
+6,300
| +225% | +$782K |
|
|
CNTN
1885
Canton Strategic Holdings
CNTN
$151M
| $1.03M | ﹤0.01% |
+339,789
| New | +$968K |
|
|
HPP
1886
Hudson Pacific Properties
HPP
$765M
| $1.03M | ﹤0.01% |
94,933
-90,209
| -49% | -$1.34M |
|
1887
KLA
KLAC
$271B
| $1.02M | ﹤0.01% |
+8,390
| New | +$984K |
|
|
SKYT
1888
DELISTED
SkyWater Technology
SKYT
| $1.02M | ﹤0.01% |
56,100
-51,911
| -48% | -$902K |
|
|
AMTM
1889
Amentum Holdings
AMTM
$5.39B
| $1.02M | ﹤0.01% |
+35,084
| New | +$897K |
|
1890
Nektar Therapeutics
NKTR
$2.57B
| $1.02M | ﹤0.01% |
+24,023
| New | +$1.34M |
|
1891
Western Alliance Bancorporation
WAL
$8.91B
| $1.02M | ﹤0.01% |
12,080
-152,633
| -93% | -$12.4M |
|
|
SA
1892
Seabridge Gold
SA
$3.52B
| $1.01M | ﹤0.01% |
34,288
-111,688
| -77% | -$2.94M |
|
1893
TIM SA
TIMB
$8.71B
| $1.01M | ﹤0.01% |
+52,129
| New | +$1.14M |
|
|
PPL
1894
PPL Corp
PPL
$26.6B
| $1.01M | ﹤0.01% |
+28,840
| New | +$1.04M |
|
1895
Cactus
WHD
$5.79B
| $1.01M | ﹤0.01% |
+22,037
| New | +$921K |
|
1896
Cathay General Bancorp
CATY
$4.29B
| $1.01M | ﹤0.01% |
20,791
+7,417
| +55% | +$357K |
|
1897
AstraZeneca
AZN
$245B
| $1M | ﹤0.01% |
5,460
-342,787
| -98% | -$60.1M |
|
1898
Enviri
NVRI
$557M
| $1M | ﹤0.01% |
+56,000
| New | +$835K |
|
|
LITS
1899
Lite Strategy Inc
LITS
$31.7M
| $1M | ﹤0.01% |
759,418
+687,460
| +955% | +$1.3M |
|
|
BDCI
1900
BTC Development Corp
BDCI
$351M
| $1M | ﹤0.01% |
+100,000
| New | +$1.01M |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.